Jana Kayserová

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

Michal Podrazil, Rudolf Horváth, Étienne Becht et al. · Oncotarget · 2015 · 136 citations · Full text

Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid

Zuzana Libá, Jana Kayserová, Martin Elišák et al. · Journal of Neuroinflammation · 2016 · 98 citations · Full text

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment

Klára Dáňová, Anna Klapetková, Jana Kayserová et al. · Oncotarget · 2015 · 57 citations · Full text

Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a <b><i>STAT3</i></b> Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?

Hana Šedivá, Petra Dušátková, Veronika Kanderová et al. · Hormone Research in Paediatrics · 2017 · 45 citations

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

Jitka Fučíková, Michal Podrazil, L. Jarolím et al. · Cancer Immunology Immunotherapy · 2017 · 45 citations · Full text

Urology, Cancer Immunosurveillance, Salvage Radiotherapy +9